A collaborative review of researchers at GIAR, Karolinska Institute (Sweden) and Edith Cowan University (Australia) on the opportunities and challenges of metabolomics in pulmonary medicine. The metabolome enables unprecedented insight into biochemistry, providing an integrated signature of the genome, transcriptome, proteome and exposome. Measurement requires rigorous protocols combined with specialized data analysis to achieve its promise.
■Title
Metabolomics in pulmonary medicine – extracting the most from your data
Stacey N. Reinke 1, Romanas Chaleckis 2,3, Craig E. Wheelock 2,3,4
1 Centre for Integrative Metabolomics & Computational Biology, School of Science, Edith Cowan University, Perth, Australia.
2 Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
3 Gunma Initiative for Advanced Research (GIAR), Gunma University, Maebashi, Japan.
4 Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.
■Journal
European Respiratory Journal (IF 16.67)
DOI 10.1183/13993003.00102-2022
■Link
